{"protocolSection":{"identificationModule":{"nctId":"NCT01845350","orgStudyIdInfo":{"id":"STR-M2-2013"},"organization":{"fullName":"Siberian Branch of the Russian Academy of Medical Sciences","class":"OTHER"},"briefTitle":"Safety of Autologous M2 Macrophage in Treatment of Non-Acute Stroke Patients","officialTitle":"Safety and Feasibility of Autologous M2 Macrophage Transplantation in Treatment of Non-Acute Stroke Patients"},"statusModule":{"statusVerifiedDate":"2016-11","overallStatus":"COMPLETED","expandedAccessInfo":{"hasExpandedAccess":false},"startDateStruct":{"date":"2012-10"},"primaryCompletionDateStruct":{"date":"2014-04","type":"ACTUAL"},"completionDateStruct":{"date":"2015-10","type":"ACTUAL"},"studyFirstSubmitDate":"2013-04-24","studyFirstSubmitQcDate":"2013-04-29","studyFirstPostDateStruct":{"date":"2013-05-03","type":"ESTIMATED"},"lastUpdateSubmitDate":"2016-11-03","lastUpdatePostDateStruct":{"date":"2016-11-04","type":"ESTIMATED"}},"sponsorCollaboratorsModule":{"responsibleParty":{"type":"PRINCIPAL_INVESTIGATOR","investigatorFullName":"Ekaterina Y. Shevela","investigatorTitle":"Senior Researcher, Laboratory of Cellular Therapy, Research Institute of Clinical Immunology","investigatorAffiliation":"Siberian Branch of the Russian Academy of Medical Sciences"},"leadSponsor":{"name":"Siberian Branch of the Russian Academy of Medical Sciences","class":"OTHER"}},"oversightModule":{"oversightHasDmc":false},"descriptionModule":{"briefSummary":"The purpose of this study is to determine whether M2 macrophages are safe and feasible in the treatment of non-acute stroke patients","detailedDescription":"Our primary hypothesis is that autologous M2 macrophage transplantation via intrathecal introduction is feasible and safe after non-acute stroke. Our secondary hypothesis is that autologous M2 macrophage transplantation is associated with improved neurological outcome after non-acute stroke"},"conditionsModule":{"conditions":["Ischemic Stroke","Hemorrhagic Stroke"]},"designModule":{"studyType":"INTERVENTIONAL","phases":["PHASE1"],"designInfo":{"allocation":"NA","interventionModel":"SINGLE_GROUP","primaryPurpose":"TREATMENT","maskingInfo":{"masking":"NONE"}},"enrollmentInfo":{"count":13,"type":"ACTUAL"}},"armsInterventionsModule":{"armGroups":[{"label":"M2 macrophages","type":"OTHER","description":"M2 macrophage introduction","interventionNames":["Other: M2 macrophage introduction"]}],"interventions":[{"type":"OTHER","name":"M2 macrophage introduction","description":"* Generation of autologous M2 macrophages from peripheral blood of non-acute stroke patients\n* Intrathecal introduction of autologous M2 macrophages","armGroupLabels":["M2 macrophages"]}]},"outcomesModule":{"primaryOutcomes":[{"measure":"The number of patients with severe adverse events","description":"Occurence of severe adverse events including mortality, neurological worsening and seizures","timeFrame":"1-3 days, 6 months"}],"secondaryOutcomes":[{"measure":"Improvement of functional outcome in National Institutes of Health Stroke Scale (NIHSS)","timeFrame":"1-3 days, 6 months"},{"measure":"Improvement in Barthel Index","timeFrame":"1-3 days, 6 months"},{"measure":"Improvement in modified Rankin scale","timeFrame":"1-3 days, 6 months"}],"otherOutcomes":[{"measure":"Number of patients with recurrent vascular episodes","timeFrame":"1-3 days, 6 months"}]},"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Computed tomography confirmed ischemic or hemorrhagic stroke\n* Duration since stroke onset more than 3 and less than 12 months\n* Age between 18 and 75 years old\n* Persistent neurological deficits more than 4 points in NIHSS stroke scale\n* Signed informed consent\n\nExclusion Criteria:\n\n* The history of previous stroke\n* Seizures\n* Thrombophilias or primary hematological diseases\n* Malignancy\n* Hepatic or renal dysfunctions\n* Hemodynamic or respiratory instability\n* Autoimmune disease\n* HIV or uncontrolled bacterial, fungal, or viral infections\n* Pregnancy\n* Participation in other clinical trials","healthyVolunteers":false,"sex":"ALL","minimumAge":"18 Years","maximumAge":"75 Years","stdAges":["ADULT","OLDER_ADULT"]},"contactsLocationsModule":{"overallOfficials":[{"name":"Elena R. Chernykh, MD, PhD","affiliation":"Research Institute of Clinical Immunology, Russian Academy of Medical Sciences (Siberian Branch)","role":"STUDY_CHAIR"}],"locations":[{"facility":"Research Institute of Clinical Immunology, Russian Academy of Medical Sciences (Siberian Branch)","city":"Novosibirsk","zip":"630099","country":"Russian Federation","geoPoint":{"lat":55.0415,"lon":82.9346}}]},"referencesModule":{"references":[{"pmid":"26671426","type":"RESULT","citation":"Chernykh ER, Shevela EY, Starostina NM, Morozov SA, Davydova MN, Menyaeva EV, Ostanin AA. Safety and Therapeutic Potential of M2 Macrophages in Stroke Treatment. Cell Transplant. 2016;25(8):1461-71. doi: 10.3727/096368915X690279. Epub 2015 Dec 14."}]}},"derivedSection":{"miscInfoModule":{"versionHolder":"2024-02-14"},"conditionBrowseModule":{"meshes":[{"id":"D000020521","term":"Stroke"},{"id":"D000083242","term":"Ischemic Stroke"},{"id":"D000083302","term":"Hemorrhagic Stroke"}],"ancestors":[{"id":"D000002561","term":"Cerebrovascular Disorders"},{"id":"D000001927","term":"Brain Diseases"},{"id":"D000002493","term":"Central Nervous System Diseases"},{"id":"D000009422","term":"Nervous System Diseases"},{"id":"D000014652","term":"Vascular Diseases"},{"id":"D000002318","term":"Cardiovascular Diseases"}],"browseLeaves":[{"id":"M21996","name":"Stroke","asFound":"Stroke","relevance":"HIGH"},{"id":"M10233","name":"Ischemia","relevance":"LOW"},{"id":"M2401","name":"Ischemic Stroke","asFound":"Ischemic Stroke","relevance":"HIGH"},{"id":"M2405","name":"Hemorrhagic Stroke","asFound":"Hemorrhagic Stroke","relevance":"HIGH"},{"id":"M5500","name":"Cerebrovascular Disorders","relevance":"LOW"},{"id":"M4894","name":"Brain Diseases","relevance":"LOW"},{"id":"M5432","name":"Central Nervous System Diseases","relevance":"LOW"},{"id":"M17090","name":"Vascular Diseases","relevance":"LOW"}],"browseBranches":[{"abbrev":"BC10","name":"Nervous System Diseases"},{"abbrev":"BC14","name":"Heart and Blood Diseases"},{"abbrev":"All","name":"All Conditions"},{"abbrev":"BC23","name":"Symptoms and General Pathology"}]}},"hasResults":false}